Labshake search
Citations for Stemcell Technologies :
501 - 550 of 1285 citations for 3 Phenoxybenzoic Acid Phenoxy 13C6 99% 100 Ug Ml In Acetonitrile since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2022Quote: ... on 1:100 diluted Geltrex (Thermo Fisher)-coated plates with daily medium changes and passaging every 3-4 days with releasing agent ReLeSR (Stemcell Technologies).
-
Pluripotent stem cell SOX9 and INS reporters facilitate differentiation into insulin-producing cellsbioRxiv - Developmental Biology 2021Quote: ... 30 ng/ml activin A (Stem Cell Technologies), and 3 µM CHIR99021 (Cayman Chemical ...
-
bioRxiv - Immunology 2021Quote: ... 50 ng/ml Epidermal Growth Factor (Stemcell Technologies), 10 nM Gastrin I ...
-
bioRxiv - Immunology 2021Quote: ... 25 ng/ml Hepatocyte Growth Factor (Stemcell Technologies), 50 ng/ml Epidermal Growth Factor (Stemcell Technologies) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 2 μg/mL Heparin (StemCell Technologies, Cat 07980), 1× antibiotic-antimicotic (Life Technologies Gibco ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 100ng/mL bFGF (Stem Cell Technologies), 50ng/mL VEGF-A (Stem Cell Technologies) ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 5ng/mL BMP4 (Stem Cell Technologies), 25ng/mL Activin A (Stem Cell Technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... heparin (2 μg/ml; Stem Cell Tech, #07980), and Antibiotic-Antimycotic solution (0.1% ...
-
bioRxiv - Neuroscience 2021Quote: Dispase (5 U/mL) (STEMCELL Technologies, Cat. 07913)
-
bioRxiv - Neuroscience 2021Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Neuroscience 2022Quote: ... 5 mL N2 supplement B (StemCell Technologies, 07156)] supplemented with SB431542 (10 µM ...
-
bioRxiv - Cancer Biology 2022Quote: ... 1 mg/ml Heparin (Stem Cell Technologies, 7980), and NSC Proliferation Supplements (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/mL heparin sulfate (Stemcell Technologies, #07980) and 5% human serum (Sigma-Aldrich ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human FGF (25ug/mL; Stem Cell Technologies), and recombinant human EGF (10 ug/mL ...
-
bioRxiv - Cell Biology 2020Quote: ... h-LDL 50 ng/ml (Stem Cell Technologies), 1% L-Glutamine (Life Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... and 1 mg/ml DNase I (Stemcell Technologies) in DMEM (Gibco ...
-
bioRxiv - Neuroscience 2022Quote: ... 3.3 μg/mL cAMP (Stem cell technologies # 73884), 3.52 μg/mL Ascorbic acid (Stem cell technologies # 72132) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 30ng/ml FGF2 and collagen (Stem Cell Technologies) at a ratio of 1:3 (collagen/medium) ...
-
bioRxiv - Neuroscience 2020Quote: ... and heparin (2 μg/mL, StemCell Technologies, #07980).
-
bioRxiv - Immunology 2020Quote: ... Human Recombinant IFNγ (10ng/mL, StemCell Technologies 78020) was added to the media for a period of 60 minutes ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/mL Heparin (Stem Cell Technologies #07980) and L-glutamine (2mM ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml GDNF (Stem Cell Technologies Cat # 78058), 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml BDNF (Stem Cell Technologies Cat # 78005), 20ng/ml GDNF (Stem Cell Technologies Cat # 78058) ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 100μg/mL SCF (StemCell Technologies 78062), 100μg/mL TPO (StemCell Technologies 78210.1) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980). All cultures were used within the first 20 passages of generation ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ml of Collagenase IV (Stem Cell Technologies) and 25μl of 10 mg/ml DNAse I (Roche) ...
-
bioRxiv - Immunology 2021Quote: ... and 0.1 U/ml dispase (STEMCELL Technologies, #07913) in DMEM supplemented with 10% FCS ...
-
bioRxiv - Immunology 2020Quote: ... with 2 mL Spleen Dissociation Medium (STEMCELL Technologies) and homogenized using the Miltenyi GentleMacs dissociator ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (StemCell Technologies, #07980); 500 μL of 25% BSA (Millipore-Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2 μg/mL heparin (Stem Cell Technologies), as previously described (Tominaga et al. ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5 mg ml-1 dispase (STEMCELL Technologies) and 1 mg ml-1 DNAse (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated with 1U/ml dispase (STEMCELL Technologies# 07923) supplemented with 0.05 mg/ml liberase (Sigma-Aldrich# 05401127001 ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 mL of ReLeSR (StemCell Technologies, cat.no. 05872) solution was applied for 30 seconds at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Neuroscience 2022Quote: ... 5 mL N2 supplement B (StemCell Technologies, 07156)] supplemented with SB431542 (10 μM ...
-
bioRxiv - Immunology 2023Quote: ... 1 µg/ml low density lipoprotein (Stemcell Technologies), 60 µM ascorbic acid (Sigma) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant EGF (20 ng/mL, human, STEMCELL Technologies) and antibiotic antimycotic solution (100x ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL hrM-CSF (Stem Cell Technologies) and 100 nM β-Estradiol (Sigma−Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... IGF-1 (40 ng/mL; Stem Cell Technologies), cholesterol-rich lipids (40 µg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... and 20 ng/ml GM-CSF (StemCell Technologies) for 8 days at 37°C ...
-
bioRxiv - Cell Biology 2023Quote: ... 5 mL (Stem Cell Technologies cat. no. 38030)
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL ActivinA (Stem Cell Technologies, 78001), and 100 μM dbcAMP (Sigma-Aldrich ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... recombinant bFGF (20 ng/mL, human, STEMCELL Technologies), recombinant EGF (20 ng/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... on 10 µg/mL Vitronectin XF (StemCell Technologies) coated plates ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL hSCF (Stem Cell Technologies 78062), 25 ng/mL Flt3 (Stem Cell Technologies 78009 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 25 ng/mL Flt3 (Stem Cell Technologies 78009) and 10 ng/mL TPO (STEMCELL Technologies 78210.1) ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10 ng/mL TPO (STEMCELL Technologies 78210.1), 10 ng/mL EPO (STEMCELL Technologies 78007) ...